The School of Pharmacy and Pharmaceutical Sciences

Contact Us The School of Pharmacy & Pharmaceutical Sciences
Panoz Institute
Trinity College Dublin
The University of Dublin
Dublin 2
Ireland
D02PN40

View the contact page for more contact and location information

pharmacy@tcd.ie
Dr. Bernard Naughton

Dr. Bernard Naughton

Associate Professor, Pharmacy

Biography

Research Interests Bernard's research focusses on two themes, 'Medicine Quality' and 'Healthcare Innovation'. More specifically he is interested in behaviours, technology, and regulation concerning the global health issue of substandard and falsified medicine. Regarding healthcare innovation, he is interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. His research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as BMJ Global Health and Lancet Global Health. He has also contributed to the regulatory affair's professional society, where he has authored several book chapters. Background Bernard is an Assistant Professor and interdisciplinary researcher at the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin where he is also the Director of the MSc in Pharmaceutical Manufacturing Technology. Prior to this appointment, Bernard was a research fellow at the Saïd Business School, and a member of St Antony's College, at the University of Oxford. Bernard holds a PhD in science and technology in medicine which was jointly supervised by the University of Oxford, Saïd Business School and the Institute of Science and Technology at Keele University. Bernard is a clinical pharmacist by training and has over ten years' experience working with large NHS teaching hospitals. Funders Bernards research has been funded by The University of Oxford, the Norwegian Research Council, the Wellcome Trust, and private technology firms. Other Engagements Bernard is an associate editor for the Sage journal 'Medicines Access at Point of Care', a tutor at the creative destructive lab at the University of Oxford, and a Visiting Senior Lecturer in the Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London. Bernard has also consulted for charities, education providers, professional and regulatory bodies, and the pharmaceutical industry.

Publications and Further Research Outputs

  • Naughton BD., Medicine authentication technology: a quantitative study of incorrect quarantine, average response times and offline issues in a hospital setting., BMJ Open, 9, (2), 2019, pe026619Journal Article, 2019, DOI
  • McManus D, Naughton BD., A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality., BMJ global health, 5, (8), 2020Journal Article, 2020, DOI
  • Naughton B, Roberts L, Dopson S, Brindley D, Chapman S., Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in secondary care., BMJ Open, 7, (5), 2017, pe013838Journal Article, 2017, DOI
  • Naughton BD, Smith JA, Brindley DA., Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety., Eur J Hosp Pharm, 23, (2), 2016, p118-120Journal Article, 2016, DOI
  • Newton PN, Bond KC, Oxford Statement signatories., Global access to quality-assured medical products: the Oxford Statement and call to action., The Lancet. Global health, 7, (12), 2019, pe1609-e1611Journal Article, 2019, DOI
  • Merks P, Swieczkowski D, Byliniak M, Drozd M, Krupa K, Jaguszewski M, Brindley DA, Naughton BD., The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists., Eur J Hosp Pharm, 25, (1), 2018, p10-15Journal Article, 2018, DOI
  • Naughton B, Roberts L, Dopson S, Chapman S, Brindley D., Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study., BMJ Open, 6, (12), 2016, pe013837Journal Article, 2016, DOI
  • Responsible innovation and commercialisation in the university context: a case study of an academic entrepreneur in digital healthcare in, editor(s)Tatiana Iakovleva, Elin M Oftedal, John Bessant , Responsible Innovation in Digital Health, Cheltenham UK, Edward Elgar Publishing, 2019, ppdoi.org/10.4337/978178 , [Bernard Naughton, Lene Foss]Book Chapter, 2019
  • DA, Pettitt, S, Raza, The Limitations of QALY: A Literature Review, Journal of Stem Cell Research & Therapy, 06, (04), 2016Journal Article, 2016, DOI
  • Naughton, BD, Vadher, B, Smith, J, Smith, G, Chapman, SR, Dopson, S, Brindley, DA, EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review, Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 12, (3-4), 2015, p95-101Journal Article, 2015, DOI
  • Naughton, Bernard D., The EU Falsified Medicines Directive: Key Implications for Dispensers, Medicine Access @ Point of Care, 1, 2017, pmaapoc.0000024Journal Article, 2017, DOI
  • Transformation2: leading a megaproject turnaround in, Edward Elgar Publishing, 2021, pp62-83 , [Naughton, Bernard, Maylor, Harvey]Book Chapter, 2021, DOI
  • Newton, Paul N, Bond, Katherine C, Adeyeye, Moji, Antignac, Marie, Ashenef, Ayenew, Awab, Ghulam Rahim, Babar, Zaheer-Ud-Din, Bannenberg, Wilbert J, Bond, Katherine C, Bower, Jason, Breman, Joel, Brock, Aleisha, Caillet, Céline, Coyne, Philip, Day, Nicholas, Deats, Michael, Douidy, Kawtar, Doyle, Kim, Dujardin, Catherine, Ejekam, Chioma S, Fernández, Facundo, Freifeld, Clark, Gill, Marie, Guerin, Philippe J, Harigwo, Georgina, Heide, Lutz, Horby, Peter, Kaur, Harparkash, Kayumba, Pierre Claver, Kazuko, Kimura, Kelly, Cassandra, Khuluza, Felix, Kigera, Stephen, Lalani, Mirza, Lamy, Marie, Lieberman, Marya, Lumpkin, Murray, Mackey, Tim, Naughton, Bernard, Newton, Paul N, Nguyen, Philip, Olliaro, Piero, Ozawa, Sachiko, Patel, Anushka, Phanouvong, Souly, Pisani, Elizabeth, Pyzik, Oksana, Rägo, Lembit, Rahman, Mohammad Sofiqur, Ranjit, Eurek, Ravinetto, Raffaella, Richmond, David, Singh-Phulgenda, Sauman, Venema, Jaap, Vogt, Andrea, White, Nicholas, Wirtz, Veronika J, Zaman, Muhammad, COVID-19 and risks to the supply and quality of tests, drugs, and vaccines, The Lancet Global Health, 8, (6), 2020, pe754-e755Journal Article, 2020, DOI
  • International Counterfeit Medicine Regulation in, Fundamentals of International Regulatory Affairs, Regulatory Affairs' Professional Society, 2017, [Naughton B, Koshkouei M, Brindley D et al]Book Chapter, 2017
  • Traceability and Supply Chain in, Fundamentals of US Regulatory Affairs, 2017, [Naughton B, Koshkouei M, Brindley D]Book Chapter, 2017
  • European Union Falsified Medicines Directive: Requirements and Implications for Multi-Stakeholder Healthcare Delivery in, Fundamentals of EU Regulatory Affairs, 2015, [Smith, J., Naughton, B., and Kramm, A]Book Chapter, 2015
  • Pathways for Prosperity Commission, The future of falsified and substandard medicine detection: digital methods to track and authenticate pharmaceutical products, 2018Report, 2018
  • Bernard Naughton (selected chapters), The Oxford Handbook of Clinical Pharmacy, Oxford University Press, 2017Book, 2017, DOI
  • Stephen R Chapman, Nicholas Thayer, Bernard Naughton, UK/USA Differences in Marketing Claim, Pharmacoepidemiology and Drug Safety, 2010Journal Article, 2010, URL
  • Bernard Naughton, Responsible impact and the reinforcement of responsible innovation in the public sector ecosystem: cases of digital health innovation, Journal of Responsible Innovation , 2023Journal Article, 2023
  • Bernard David Naughton, Ebru Akgul, Medicine quality in high-income countries: The obstacles to comparative prevalence studies, Medicine Access @ Point of Care, 5, 2021, p239920262110522Journal Article, 2021, DOI
  • BD Naughton, MJ Gill, M Field, S Shaw, Impure innovation: Intra-professional stigmatization of radical ideas, 39th EGOS Colloquium, Cagliari 2023, Cagliari, Italy, 2023Oral Presentation, 2023
  • Muireann Counihan, Larisa Cervenakova, Dominika Misztela, Maarten Van Baelen and Bernard D. Naughton, Access and use of immunoglobulins in secondary supportive cancer care: A systematic literature review, The Journal of Medicine Access, 2023, p10.1177/27550834231197315Journal Article, 2023
  • Niarchou E, Roberts LH, Naughton BD., What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review., Journal of psychopharmacology (Oxford, England), 38, (2), 2024, p127-136Journal Article, 2024, DOI
  • Bernard Naughton, Pharmaceutical Serialisation & Traceability; Approaches, Legislation, Challenges & Opportunities , Tackling Illicit Trade in Trinidad and Tobago, Online, July , 2021, British High CommissionInvited Talk
  • Bernard Naughton, Counterfeit medicine, illegal substances and Falsified Medicines Directive (FMD), Royal Pharmaceutical Society of Great Britain Science and Research Summit, London, 2019, Royal Pharmaceutical Society of Great BritainInvited Talk
  • Bernard Naughton, Fulfilling Patient Needs; A View From The Sharp End, 22nd European Association of Hospital Pharmacists Conference, Cannes, France, March, 2017, European Associate of Hospital PharmacistsInvited Talk
  • Bernard Naughton, West Midlands Chief Pharmacist Symposium, England, Staffordshire, 2018Invited Talk
  • Bernard Naughton, 5th Annual Anti-Counterfeiting and Serialisation Conference, London, 2016Invited Talk
  • Bernard Naughton, 7th Annual Anti-Counterfeiting and Serialisation Conference, London, 2018Invited Talk
  • Bernard Naughton, 3rd Anti-Counterfeiting Pharma Conference, London, 2017Invited Talk
  • Bernard Naughton, 23rd European Association of Hospital Pharmacists Conference, Gothenburg, 2018Invited Talk
  • Bernard Naughton, In a time of pandemic, we need to stamp out quackery, Oxford, UK, 2020Report, URL
  • Bernard Naughton, Combating Counterfeit Medicines: Legal Frameworks and Emerging Technologies, The Regulatory Affairs Professional Society, 2016Journal Article, URL
  • L Roberts, BD Naughton, E Niarchiou, Patient Perspectives of medicine use, adherence and doctor-patient communication: A Service Evaluation of the "Open Up About Medicines" Campaign, Midlands Health Psychology Network 18th Annual Conference, 26, Online, 2023Poster
  • EN L. Roberts, B.D. Naughton, An analysis of the impact of antidepressant side effects on medication adherence among adults with a diagnosed mental disorder, All Ireland Schools of Pharmacy Conference, 2023Oral Presentation

Research Expertise

My research focusses on two themes, 1. Medicine Quality and 2. Healthcare Innovation. More specifically he is interested in estimating the problem as well as behaviour, technology, and regulation concerning substandard and falsified medicine. Regarding healthcare innovation, I am interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. My research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as BMJ Global Health and Lancet Global Health. I have also contributed to the regulatory affair's professional society, where I have authored several book chapters.

  • Title
    The Future of Falsified and Substandard Medicine. Detection: Digital Methods to Track and Authenticate Pharmaceutical Products. A policy case study.
    Summary
    Working with the Blavatnik School of Government at the University of Oxford and as part of the Pathways for Prosperity project I contributed a case study regarding digital technologies to address the issue of substandard and falsified medicines in low income countries.
    Funding Agency
    Bill and Melinda Gates Foundation.
    Date From
    2017
    Date To
    2018
  • Title
    Hybrid stigma in the digital research and innovation context
    Summary
    This study investigated the effect of Stigma on Innovation in the digital health sector
    Funding Agency
    Wellcome Trust

Economics and Business Administration, Public health, Health services and systems,

Recognition

  • Regulatory Affairs Professional Society Current
  • Royal Pharmaceutical Society of Great Britain Current
  • Academy of Management Current
  • Journal reviewer for the Journal of King Saud University
  • Reviewer for the MDPI journal Pharmacy
  • External Examiner for Technological University Dublin 2023
  • Reviewer for Lancet Oncology
  • Journal Reviewer for Health Services Research (2022)
  • Journal reviewer for Health Services Research
  • Associate Editor for the Journal of Medicine Access
  • Journal reviewer for the International Journal of Environmental Research and Public Health (Reviewer Board Member)
  • Associate Editor: Journal of Medicine Access 2021
  • Regular Journal Reviewer for BMJ Global Health
  • QP Forum Steering Committee Member 2021
  • Visiting Senior Lecturer, Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London 2021
  • Editorial Board Member at The Journal of Medicine Access 2017
  • Reviewer for Therapeutic Innovation and Regulatory Science
  • Principal Consultant. Solfen Healthcare Limited. 2011
  • Reviewer Board member for The International Journal of Environmental Research and Public Health 2021
  • Falsified Medicines Advisory board member for UK Government MHRA (Medicines Healthcare and Regulatory Authority). 2018-2019
  • Journal reviewer for the Academy of Management
  • External Examiner South East Technological University 2023
  • Reviewer for Sustainability